ICUI Icu Medical Inc
- Stocks
- Healthcare
- NASDAQ: ICUI
Price (delayed)
$113.27
Market cap
$2.8B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.53
Enterprise value
$3.83B
ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system
Highlights
ICUI's net income has surged by 61% since the previous quarter and by 48% year-on-year
ICUI's EPS has soared by 60% from the previous quarter and by 48% YoY
Key stats
What are the main financial stats of ICUI
Market
Valuations
Earnings
Shares outstanding
24.69M
Market cap
$2.8B
Enterprise value
$3.83B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.32
Price to sales (P/S)
1.18
EV/EBIT
35.96
EV/EBITDA
11.46
EV/Sales
1.62
Revenue
$2.37B
Gross profit
$850.28M
Operating income
$64.05M
Net income
-$36.95M
EBIT
$106.62M
EBITDA
$334.53M
Free cash flow
$50.61M
Per share
Balance sheet
Liquidity
EPS
-$1.53
EPS diluted
-$1.53
Free cash flow per share
$2.05
Book value per share
$85.97
Revenue per share
$96.27
TBVPS
$77.4
Total assets
$4.11B
Total liabilities
$1.99B
Debt
$1.34B
Equity
$2.12B
Working capital
$697.34M
Debt to equity
0.63
Current ratio
2.44
Quick ratio
0.99
Net debt/EBITDA
3.1
Margins
Efficiency
Dividend
EBITDA margin
14.1%
Gross margin
35.8%
Net margin
-1.6%
Operating margin
2.7%
Return on assets
-0.9%
Return on equity
-1.8%
Return on invested capital
4%
Return on capital employed
2.9%
Return on sales
4.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ICUI stock price
How has the Icu Medical stock price performed over time
Intraday
2.67%
1 week
-10.73%
1 month
-14.29%
1 year
-24.52%
YTD
-27%
QTD
-14.29%
Financial performance
How have Icu Medical's revenue and profit performed over time
Revenue
$2.37B
Gross profit
$850.28M
Operating income
$64.05M
Net income
-$36.95M
Gross margin
35.8%
Net margin
-1.6%
ICUI's net income has surged by 61% since the previous quarter and by 48% year-on-year
The net margin has surged by 59% since the previous quarter and by 48% year-on-year
ICUI's gross profit is up by 14% YoY
ICUI's gross margin is up by 10% year-on-year
Price vs fundamentals
How does ICUI's price correlate with its fundamentals
Growth
What is Icu Medical's growth rate over time
Valuation
What is Icu Medical stock price valuation
P/E
N/A
P/B
1.32
P/S
1.18
EV/EBIT
35.96
EV/EBITDA
11.46
EV/Sales
1.62
ICUI's EPS has soared by 60% from the previous quarter and by 48% YoY
The stock's price to book (P/B) is 39% less than its 5-year quarterly average of 2.1 and 29% less than its last 4 quarters average of 1.8
Icu Medical's equity has increased by 6% QoQ and by 3.8% YoY
ICUI's P/S is 48% less than its 5-year quarterly average of 2.2 and 28% less than its last 4 quarters average of 1.6
The revenue is up by 3% year-on-year
Efficiency
How efficient is Icu Medical business performance
The ROIC has soared by 111% from the previous quarter
ICUI's ROS has soared by 105% from the previous quarter
Icu Medical's ROE has soared by 62% from the previous quarter and by 47% YoY
ICUI's return on assets has surged by 59% since the previous quarter and by 44% year-on-year
Dividends
What is ICUI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ICUI.
Financial health
How did Icu Medical financials performed over time
The total assets is 106% greater than the total liabilities
ICUI's quick ratio is up by 18% since the previous quarter and by 11% year-on-year
The total liabilities has contracted by 11% YoY and by 9% from the previous quarter
The debt is 37% smaller than the equity
The debt to equity has declined by 20% year-on-year and by 18% since the previous quarter
The debt has declined by 17% year-on-year and by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.